5-HYDROXYTRYPTAMINE and the Pulmonary Circulation: Receptors, Transporters and Relevance to Pulmonary Arterial Hypertension (original) (raw)

Functional Interactions between 5-Hydroxytryptamine Receptors and the Serotonin Transporter in Pulmonary Arteries

Journal of Pharmacology and Experimental Therapeutics, 2004

In vivo effects of a combined 5-HT1B receptor/SERT antagonist in experimental pulmonary hypertension

Cardiovascular Research, 2010

5-Hydroxytryptamine receptors mediating vasoconstriction and vasodilation in perinatal and adult rabbit small pulmonary arteries

M. Houslay, Margaret Maclean

British Journal of Pharmacology, 1998

View PDFchevron_right

PRX-08066, a Novel 5Hydroxytryptamine Receptor 2B Antagonist, Reduces Monocrotaline-Induced Pulmonary Arterial Hypertension and Right Ventricular Hypertrophy in Rats

sean faris

Journal of Pharmacology and Experimental Therapeutics, 2010

View PDFchevron_right

Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension

jacques callebert

Nature Medicine, 2002

View PDFchevron_right

Transgenic Mice Overexpressing the 5-Hydroxytryptamine Transporter Gene in Smooth Muscle Develop Pulmonary Hypertension

Christophe Guignabert

Circulation Research, 2006

View PDFchevron_right

Novel 5-hydroxytryptamine Receptor 2 B ( 5-HT 2 B ) Receptor Antagonist , Reduces Monocrotaline-induced Pulmonary Arterial Hypertension and Right Ventricular Hypertrophy in Rats

Faris al-Mousily

2010

View PDFchevron_right

Heterogeneity in 5-HT-Induced Contractile and Proliferative Responses in Rat Pulmonary Arterial Bed

J.-p. Savineau, Lise Rodat-despoix

Journal of Vascular Research, 2008

View PDFchevron_right

Serotonin Signaling in Pulmonary Hypertension

M. Caestecker

Circulation Research, 2006

View PDFchevron_right

Serotonin Transporter Inhibition Prevents and Reverses Monocrotaline-Induced Pulmonary Hypertension in Rats

Christophe Guignabert

Circulation, 2005

View PDFchevron_right

Characterization of 5HT receptors on human pulmonary artery and vein: functional and binding studies

Andres Fernandez

British Journal of Pharmacology, 1997

View PDFchevron_right

High Plasma Serotonin Levels in Primary Pulmonary Hypertension

philippe herve

Arteriosclerosis, Thrombosis, and Vascular Biology, 2000

View PDFchevron_right

Serotonin Transporter Inhibitors Protect against Hypoxic Pulmonary Hypertension

Minh Khôi Phạm

American Journal of Respiratory and Critical Care Medicine, 2003

View PDFchevron_right

The existence of a local 5-hydroxytryptaminergic system in peripheral arteries

Jessica Priestley

British Journal of Pharmacology, 2008

View PDFchevron_right

Contribution of the 5-HT1B Receptor to Hypoxia-Induced Pulmonary Hypertension: Converging Evidence Using 5-HT1B-Receptor Knockout Mice and the 5-HT1B/1D-Receptor Antagonist GR127935

Margaret Maclean

Circulation Research, 2001

View PDFchevron_right

Serotonin-Induced Smooth Muscle Hyperplasia in Various Forms of Human Pulmonary Hypertension

Gerald Simonneau

2009

View PDFchevron_right

Plasma serotonin levels are normal in pulmonary arterial hypertension

David J Lederer

Pulmonary Pharmacology & Therapeutics, 2008

View PDFchevron_right

Serotonin 5-HT2B receptors are required for bone-marrow contribution to pulmonary arterial hypertension

Corinne Collet

Blood, 2012

View PDFchevron_right

C-122, a novel antagonist of serotonin receptor 5-HT< sub> 2B, prevents monocrotaline-induced pulmonary arterial hypertension in rats

Peter Senese

European Journal of …, 2011

View PDFchevron_right

Sex Hormones and Vascular Protection in Pulmonary Arterial Hypertension

Helen Christou

Journal of Cardiovascular Pharmacology, 2010

View PDFchevron_right

Rodent models of PAH: are we there yet?

Ivan McMurtry

AJP: Lung Cellular and Molecular Physiology, 2007

View PDFchevron_right

Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors/mechanisms involved and therapeutic implications

David Centurión

Naunyn-Schmiedeberg's Archives of Pharmacology, 2007

View PDFchevron_right

The Pulmonary Hypertensive Fawn-hooded Rat Has a Normal Serotonin Transporter Coding Sequence

AnaMaria Gonzalez

American Journal of Respiratory Cell and Molecular Biology, 1998

View PDFchevron_right

C-122, a novel antagonist of serotonin receptor 5-HT2B, prevents monocrotaline-induced pulmonary arterial hypertension in rats

Liomar Neves

European Journal of Pharmacology, 2011

View PDFchevron_right

Venous plasma serotonin is not a proper biomarker for pulmonary arterial hypertension

Helge Waldum

Scandinavian Cardiovascular Journal, 2014

View PDFchevron_right

Overexpression of the 5-Hydroxytryptamine Transporter Gene

Janet Colston

Circulation, 2004

View PDFchevron_right

5-HT moduline: an endogenous inhibitor of 5-HT 1B/1D -mediated contraction in pulmonary arteries

I. Morecroft

British Journal of Pharmacology, 2003

View PDFchevron_right

Expression of the serotonin 1b receptor in experimental pulmonary hypertension

S. Brimioulle

European Respiratory Journal, 2003

View PDFchevron_right

Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension

Werner Seeger

Journal of the American College of Cardiology, 2004

View PDFchevron_right

5-HYDROXYTRYPTAMINE and the Pulmonary Circulation: Receptors, Transporters and Relevance to Pulmonary Arterial Hypertension (original) (raw)

Related papers